HCRT and Anxiety: The idea was to investigate whether SB-649868 could have effects on these systems by inhibiting abnormally activated orexin signaling, such as is thought to occur in anxiety or panic disorders (Li et al. 2010; Johnson et al., 2012a, 2012b).